Optimizing the design of a contraceptive microarray patch: a discrete choice experiment on women's preferences in India and Nigeria.

Rebecca L CallahanAurélie BrunieVictoria LebrunMario ChenChristine L GodwinKanchan LakhwaniFunmilola M OlaOlorun

Published in: Reproductive health (2021)

To the extent possible, MAP developers should consider method designs and formulations that limit menstrual side effects and provide more than one month of protection.

Keyphrases

polycystic ovary syndrome
decision making
pregnancy outcomes
cervical cancer screening
breast cancer risk
type diabetes
metabolic syndrome
pregnant women
adipose tissue
skeletal muscle